Conventional diagnostic methods for bacterial meningitis are frequently not
rapid or sensitive enough to guide initial antimicrobial therapy. Streptoc
occus pneumoniae is the most frequent and severe cause of community-acquire
d bacterial meningitis and treatment is complicated by the Increasing preva
lence of antimicrobial resistance to third-generation cephalosporins. We us
ed a new rapid antigen test in the cerebrospinal fluid and urine of patient
s with suspected bacterial meningitis, and found It to be highly sensitive
and specific for the detection of pneumococci. This test might help guide I
nitial therapy for bacterial meningitis according to the local rates of pne
umococcal antimicrobial resistance.